Extract
Threshold values play a critical role in clinical medicine, as they provide standardised criteria for diagnosis and treatment, ensuring consistency across different healthcare providers and settings. They help in maintaining uniformity in patient care, making sure that patients with similar characteristics receive similar evaluations and interventions. They also aid in risk stratification, allowing for targeted interventions for high-risk individuals, thereby optimising resource allocation and improving outcomes. For instance, lung function thresholds can help identify patients at risk for COPD and initiate appropriate management, such as help with smoking cessation [1]. And on the topic of thresholds and smoking, in many clinical settings across the globe, a COPD diagnosis is mainly considered in individuals with more than 10 or even 20 pack-years of smoking history, and randomised controlled trials of COPD patients most often use the 10 pack-year threshold as an inclusion criterion [2]. Tobacco use is indeed the single most preventable cause of both death and disease [3], but this 10 pack-years of smoking threshold with regards to COPD risk is, however, mainly based on tradition and not so much on solid scientific evidence.
Shareable abstract
Although the threshold of 10 pack-years of smoking is often used in clinical decision-making for COPD, it is not evidence-based and should be re-evaluated https://bit.ly/3VMWZoE
Footnotes
Conflict of interest: H. Backman has no potential conflicts of interest to disclose.
Support statement: This work was supported by Hjärt-Lungfonden (grant 20210240) and Forskningsrådet om Hälsa, Arbetsliv och Välfärd (grant 2022-00381). Funding information for this article has been deposited with the Crossref Funder Registry.
- Received June 25, 2024.
- Accepted June 27, 2024.
- Copyright ©The authors 2024. For reproduction rights and permissions contact permissions{at}ersnet.org